Elton Amp Dudink1, Bob Weijs1, Samantha Tull2, Justin Glm Luermans1, Larissa Fabritz2, Winnie Chua2, Michiel Rienstra3, Isabelle C Van Gelder3, Ulrich Schotten4, Paulus Kirchhof2,5,6, Harry Jgm Crijns1. 1. Maastricht University Medical Center+ and Cardiovascular Research Institute Maastricht (CARIM), Department of Cardiology, Maastricht, the Netherlands. 2. University of Birmingham, Institute of Cardiovascular Sciences, Birmingham, United Kingdom. 3. University Medical Center Groningen, Department of Cardiology, Groningen, the Netherlands. 4. Maastricht University and Cardiovascular Research Institute Maastricht (CARIM), Department of Physiology, Maastricht, the Netherlands. 5. Sandwell and West Birmingham Hospitals and University Hospitals Birmingham NHS trusts, Birmingham, United Kingdom. 6. AFNET, Münster, Germany.
Abstract
BACKGROUND: Blood biomarkers related to AF could be useful to detect silent AF and to develop stratified strategies for AF prevention. Previous studies identified markers that predict incident AF. However, it is difficult to differentiate whether biomarkers relate to underlying cardiovascular diseases, are generated by the atria in response to an AF episode, or both. We therefore measured a panel of blood biomarkers in patients without overt CVD with and without AF to investigate the association between biomarkers and atrial fibrillation (AF) in patients without overt cardiovascular disease (CVD). METHODS: Blood samples - drawn remote from an AF episode - of 60 patients with AF but without overt forms of CVD (idiopathic AF; iAF) were compared to 120 matched patients with sinus rhythm only. A novel antibody-based method for quantification of blood biomarkers (OlinkProseek Multiplex Cardiovascular) was used to compare 92 biomarkers between the two groups. RESULTS: N-terminal pro-B-type natriuretic peptide (NT-proBNP), Cathepsin L1, Endothelial cell-specific molecule 1, Cancer Antigen-125 (CA-125), Heat shock 27kDa protein, Galanin peptides, Proteinase-activated receptor 1, Stem cell factor, and CD40-ligand were all higher in iAF patients than in SR controls. Both NT-proBNP (OR1.55(1.07-2.25);p=0.022) and CA-125 (OR1.68(1.07-2.64);p=0.026) were independently associated with iAF. CONCLUSIONS: This exploratory study, investigating over 90 cardiovascular blood biomarkers in patients without known CVD, identified one established biomarker for paroxysmal AF, NT-proBNP, and a novel marker, CA-125. CA-125 - previously unrelated to paroxysmal AF in an otherwise healthy population - may thus be a potential indicator of remote paroxysms of AF.
BACKGROUND: Blood biomarkers related to AF could be useful to detect silent AF and to develop stratified strategies for AF prevention. Previous studies identified markers that predict incident AF. However, it is difficult to differentiate whether biomarkers relate to underlying cardiovascular diseases, are generated by the atria in response to an AF episode, or both. We therefore measured a panel of blood biomarkers in patients without overt CVD with and without AF to investigate the association between biomarkers and atrial fibrillation (AF) in patients without overt cardiovascular disease (CVD). METHODS: Blood samples - drawn remote from an AF episode - of 60 patients with AF but without overt forms of CVD (idiopathic AF; iAF) were compared to 120 matched patients with sinus rhythm only. A novel antibody-based method for quantification of blood biomarkers (OlinkProseek Multiplex Cardiovascular) was used to compare 92 biomarkers between the two groups. RESULTS: N-terminal pro-B-type natriuretic peptide (NT-proBNP), Cathepsin L1, Endothelial cell-specific molecule 1, Cancer Antigen-125 (CA-125), Heat shock 27kDa protein, Galanin peptides, Proteinase-activated receptor 1, Stem cell factor, and CD40-ligand were all higher in iAF patients than in SR controls. Both NT-proBNP (OR1.55(1.07-2.25);p=0.022) and CA-125 (OR1.68(1.07-2.64);p=0.026) were independently associated with iAF. CONCLUSIONS: This exploratory study, investigating over 90 cardiovascular blood biomarkers in patients without known CVD, identified one established biomarker for paroxysmal AF, NT-proBNP, and a novel marker, CA-125. CA-125 - previously unrelated to paroxysmal AF in an otherwise healthy population - may thus be a potential indicator of remote paroxysms of AF.
Authors: Carmen Urbich; Christopher Heeschen; Alexandra Aicher; Ken-ichiro Sasaki; Thomas Bruhl; Mohammad R Farhadi; Peter Vajkoczy; Wolf K Hofmann; Christoph Peters; Len A Pennacchio; Nasreddin D Abolmaali; Emmanouil Chavakis; Thomas Reinheckel; Andreas M Zeiher; Stefanie Dimmeler Journal: Nat Med Date: 2005-01-23 Impact factor: 53.440
Authors: Mei Sun; Manyin Chen; Youan Liu; Masahiro Fukuoka; Kim Zhou; Guohua Li; Fayez Dawood; Anthony Gramolini; Peter P Liu Journal: Cardiovasc Res Date: 2010-12-08 Impact factor: 10.787
Authors: Bob Weijs; Ron Pisters; Rutger J Haest; Johannes A Kragten; Ivo A Joosen; Mathijs Versteylen; Carl C Timmermans; Laurent Pison; Yuri Blaauw; Leonard Hofstra; Robby Nieuwlaat; Joachim Wildberger; Harry J Crijns Journal: Heart Rhythm Date: 2012-08-08 Impact factor: 6.343
Authors: Robby Nieuwlaat; Martin H Prins; Jean-Yves Le Heuzey; Panos E Vardas; Etienne Aliot; Massimo Santini; Stuart M Cobbe; Jos W M G Widdershoven; Leo H Baur; Samuel Lévy; Harry J G M Crijns Journal: Eur Heart J Date: 2008-04-07 Impact factor: 29.983
Authors: Kristen K Patton; Susan R Heckbert; Alvaro Alonso; Hossein Bahrami; Joao A C Lima; Gregory Burke; Richard A Kronmal Journal: Heart Date: 2013-10-16 Impact factor: 5.994
Authors: Bryan Kestenbaum; Michael C Sachs; Andy N Hoofnagle; David S Siscovick; Joachim H Ix; Cassianne Robinson-Cohen; Joao A C Lima; Joseph F Polak; Marc Blondon; John Ruzinski; Denise Rock; Ian H de Boer Journal: Circ Heart Fail Date: 2014-03-25 Impact factor: 8.790
Authors: Jens P Goetze; Benoit G Bruneau; Hugo R Ramos; Tsuneo Ogawa; Mercedes Kuroski de Bold; Adolfo J de Bold Journal: Nat Rev Cardiol Date: 2020-05-22 Impact factor: 32.419
Authors: Denise M S van Marion; Eva A H Lanters; Kennedy S Ramos; Jin Li; Marit Wiersma; Luciënne Baks-Te Bulte; Agnes J Q M Muskens; Eric Boersma; Natasja M S de Groot; Bianca J J M Brundel Journal: Cells Date: 2020-09-16 Impact factor: 6.600
Authors: Winnie Chua; Jonathan P Law; Victor R Cardoso; Yanish Purmah; Georgiana Neculau; Muhammad Jawad-Ul-Qamar; Kalisha Russell; Ashley Turner; Samantha P Tull; Frantisek Nehaj; Paul Brady; Peter Kastner; André Ziegler; Georgios V Gkoutos; Davor Pavlovic; Charles J Ferro; Paulus Kirchhof; Larissa Fabritz Journal: PLoS Med Date: 2021-02-03 Impact factor: 11.069
Authors: Valentina Bracun; Navin Suthahar; Canxia Shi; Sanne de Wit; Wouter C Meijers; IJsbrand T Klip; Rudolf A de Boer; Joseph Pierre Aboumsallem Journal: Front Cardiovasc Med Date: 2021-12-08
Authors: Ruben R De With; Vicente Artola Arita; Bao-Oanh Nguyen; Dominik Linz; Hugo Ten Cate; Henri Spronk; Ulrich Schotten; Anton Jan van Zonneveld; Ömer Erküner; M Agustina Bayón; Anders S Schmidt; Justin G L M Luermans; Harry J G M Crijns; Isabelle C Van Gelder; Michiel Rienstra Journal: Europace Date: 2022-02-02 Impact factor: 5.214
Authors: Tymon Pol; Ziad Hijazi; Johan Lindbäck; Jonas Oldgren; John H Alexander; Stuart J Connolly; John W Eikelboom; Michael D Ezekowitz; Christopher B Granger; Renato D Lopes; Salim Yusuf; Agneta Siegbahn; Lars Wallentin Journal: Cardiovasc Res Date: 2022-07-20 Impact factor: 13.081